Oral Solid Dosage Pharmaceutical Formulation Market -Global Industry Analysis and Forecast (2023-2029)


Oral Solid Dosage Pharmaceutical Formulation Market size was valued at US$ 679.53 Bn in 2022 and the total revenue is expected to grow at 7.10% through 2023 to 2029, reaching nearly US$ 1098.34 Bn.

Oral Solid Dosage Pharmaceutical Formulation Market Overview:

The fundamental procedure used by many medication companies is known as oral solid dosage pharmaceutical Dosage Formulation. The solid Dosage Form of medicine is thought to be the most practical way to get the exact dose for a variety of acute and chronic disorders. The creation of oral dosage Dosage Forms of medications is also a very simple and cost-effective method for drug manufacturers. As a result of the growing popularity of the Dosage Formulation, the worldwide Oral Solid Dosage Pharmaceutical Formulation market is expected to rise significantly over the forecast period.

Oral Solid Dosage Pharmaceutical Formulation Market Snapshot

Global Oral Solid Dosage Pharmaceutical Formulation MarketTo know about the Research Methodology :- Request Free Sample Report

Oral Solid Dosage Pharmaceutical Formulation Market Dynamics:

The majority of oral solid dosage Dosage Forms are used in pharmaceuticals for the treatment of a variety of diseases. Manufacturers find it easy to make these dosage Dosage Forms of medicine, and they are also cost-effective, which play a significant part in the growth of the global Oral Solid Dosage Pharmaceutical Formulation market in the future. These dose Dosage Forms are very simple to pack and transport and are temperature resistant. These dosage Dosage Forms also have better physical and chemical stability, which bodes well for the industry shortly.

Oral solid dose Dosage Forms, in addition to drug makers, provide various advantages to patients. Patients do not have to bother about dose-measuring with this type of oral administration and can easily administer the required amount of medicament as prescribed by physicians. These Dosage Formulations can come in a variety of shapes and flavors in order to improve patient compliance, which is projected to play a big part in increasing demand for oral solid dose pharmaceutical Dosage Formulations in the future.

The pandemic of COVID-19 has had a huge impact on the market. Lockdowns in 2019 and rigorous rules and regulation imposed by the government created a shortage of human resources, contributing to the reduction of oral solid dosages. It also caused a serious interruption in the input materials distribution network, which resulted in development efforts being delayed. As a result of the pandemic, a huge number of pharmaceutical companies have shifted their focus to the development of COVID-19 drugs. Further, quick changes in contract manufacturing companies' business models and improved conditions as a result of the introduction of vaccines are estimated to show a bright future in the pharmaceutical market.

Oral Solid Dosage Pharmaceutical Formulation Market Segment Analysis:

The Tablet segment is anticipated to adhere to the growth of the Oral Solid Dosage Pharmaceutical Formulation Market.

The tablet segment is dominating the market with a share of 55.6% in 2022. A tablet is a solid dose Dosage Form used in pharmaceuticals. Tablets can be defined as a solid unit dosage Dosage Form of a medication or a combination of medications with appropriate excipients. It is made up of a powdered mixture of active ingredients and excipients that is pressed or compressed into a solid dosage. In addition, Tablets have a prolonged lifespan and are available in a range of shapes and sizes. In addition, they can hold a greater dose of an active substance than a capsule. Further, tablets are simple and convenient to use and some of the tablets are sugar-coated to mask their taste and increase the acceptancy, hence this factor is likely to hit the growth of the market in near future.

The Extended Release segment is supplementing the growth of the Oral Solid Dosage Pharmaceutical Formulation Market.

The term oral extended-release medications refers to products that change the timing or rate at which a drug substance is released. Subcutaneous and intramuscular injections of suspensions of insoluble drug complexes are common in earlier modified-release products. Furthermore, technological advancements have resulted in the development of unique oral modified release dosage Dosage Formulations. Modified release, prolonged release, controlled release, and sustained release are just a few of the words that are used to describe oral extended-release tablets. In the near future, the oral extended-release tablets market will be driven by the advantages of oral extended-release tablets over traditional dosage Dosage Forms, as well as increased research and development for novel medication development and therapy.

The market for oral extended-release tablets is fueled by the rising prevalence of chronic diseases that necessitate high medication plasma concentrations, reduced side effects, and improved patient compliance due to reduced doses. Moreover, the key factor driving the growth of the market is cost-effective production as the number of pills required per patient is reduced when compared to the conventional Dosage Form.

Oral Solid Dosage Pharmaceutical Formulation Market Regional Insights:

In terms of revenue, North America led the global Oral Solid Dosage Pharmaceutical Formulation market in 2022, and this trend is projected to continue over the forecast timeframe. With a CAGR of 6.7%, North America is predicted to be the most profitable of all areas. The market in the region is growing as the pharmaceutical industry in the United States consolidates and outsourcing expands. Further, growing advanced infrastructure in the region and various manufacturing technologies are likely to boost the growth of the market in the coming future. The dominating countries of North America are the US, Canada, followed by Mexico. Also, rising awareness in consumers regarding the sustained release and controlled release tablets is likely to fuel the market growth in the region. Moreover, the increasing production capacity of various pharmaceutical industries is projected to support the growth of the regional market.

The objective of the report is to present a comprehensive analysis of the Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the Market dynamics, structure by analyzing the market segments and project the Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Market make the report investor’s guide.

Oral Solid Dosage Pharmaceutical Formulation Market Scope: Inquire before buying






Global Oral Solid Dosage Pharmaceutical Formulation Market




Report Coverage
Details




Base Year:
2022
Forecast Period:
2023-2029




Historical Data:
2018 to 2022
Market Size in 2022:
US $ 679.53 Bn.




Forecast Period 2023 to 2029 CAGR:
7.10%
Market Size in 2029:
US $ 1098.3 Bn.




 Segments Covered:
by Dosage Form
Capsules
Tablets
Powder
Others




by Drug Release Mechanism
Immediate Release
Extended Release
 Sustained Release
  Controlled Release
Others




by Distribution Channel
Hospital pharmacies
Retail pharmacies
Drug Stores
Online Pharmacy






Oral Solid Dosage Pharmaceutical Formulation Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and the Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and the Rest of APAC)
South America (Brazil, Argentina Rest of South America)
Middle East & Africa (South Africa, GCC, Egypt, Nigeria and the Rest of ME&A)

Oral Solid Dosage Pharmaceutical Formulation Market Key Players

1. Takeda Pharmaceutical Company Limited
2. Merck & Co., Inc., d.b.a
3. Corealis Pharma Inc.
4. Astellas Pharma Inc.
5. CordenPharma International
6. Bayer AG
7. AbbVie Inc.
8. Thermo Fisher Scientific Inc. (Patheon N.V.)
9. Lonza
10. Catalent Inc.
11. Alcami Corporation
12. Halo Pharmaceutical Inc.
13. CordenPharma International
14. Arnet Pharmaceuticals
15. Jubilant Life Sciences
16. Pfizer Inc.
17. Piramal EnterprisesLtd
18. Metrics Contract Services
19. GENVION Corporation
20. GlaxoSmithKline plc.
21. CMIC HOLDINGS Co., LTD.
22. Tower Laboratories Ltd.
23. PNP Pharmaceuticals Inc.
24. Confab Laboratories Inc.
25. Wockhardt Ltd.
26. Pharma Tech Industries

Frequently Asked Questions:

1. Which region has the largest share in Global Oral Solid Dosage Pharmaceutical Formulation Market?
Ans: North America region held the highest share in 2022.

2. What is the growth rate of Global Oral Solid Dosage Pharmaceutical Formulation Market?
Ans: The Global Market is expected to grow at a CAGR of 7.10% during forecast period 2023-2029.

3. What is scope of the Global Oral Solid Dosage Pharmaceutical Formulation market report?
Ans: Global Oral Solid Dosage Pharmaceutical Formulation Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Oral Solid Dosage Pharmaceutical Formulation market?
Ans: The important key players in the Global Market are – , Takeda Pharmaceutical Company Limited, Merck & Co., Inc., d.b.a, Corealis Pharma Inc., Astellas Pharma Inc., CordenPharma International, Bayer AG, AbbVie Inc., Thermo Fisher Scientific Inc. (Patheon N.V.), Lonza, Catalent Inc., Alcami Corporation, Halo Pharmaceutical Inc., CordenPharma International, Arnet Pharmaceuticals, Jubilant Life Sciences, Pfizer Inc., Piramal EnterprisesLtd, Metrics Contract Services, GENVION Corporation, GlaxoSmithKline plc., CMIC HOLDINGS Co., LTD., Tower Laboratories Ltd., PNP Pharmaceuticals Inc., Confab Laboratories Inc., Wockhardt Ltd., Pharma Tech Industries, and.

5. What is the study period of this market?
Ans: The Global Oral Solid Dosage Pharmaceutical Formulation Market is studied from 2022 to 2029. 




1.Preface
1.1. Market Definition and Key Research Objectives
1.2. Research Highlights
2. Assumptions and Research Drug Release Mechanism
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Drug Release Mechanism
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Drug Release Mechanism
2.3.2. Primary Research
2.3.2.1. Data from Primary Drug Release Mechanism
2.3.2.2. Breakdown of Primary Drug Release Mechanism
3. Executive Summary: Oral Solid Dosage Pharmaceutical Formulation Market Size, by Market Value (US$ Bn)
3.1. Global Market Segmentation
3.2. Global Market Segmentation Share Analysis, 2021
3.2.1. Global
3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
3.3. Geographical Snapshot of the Oral Solid Dosage Pharmaceutical Formulation Market
3.4. Geographical Snapshot of the Oral Solid Dosage Pharmaceutical Formulation Market, By Manufacturer share
4. Oral Solid Dosage Pharmaceutical Formulation Market Overview, 2022-2029
4.1. Market Dynamics
4.1.1. Drivers
4.1.1.1. Global
4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.2. Restraints
4.1.2.1. Global
4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.3. Opportunities
4.1.3.1. Global
4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.4. Challenges
4.1.4.1. Global
4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.5. Industry Trends and Emerging Technologies
4.1.6. Porter Five Forces Analysis
4.1.6.1. The threat of New Entrants
4.1.6.2. Bargaining Power of Buyers/Consumers
4.1.6.3. Bargaining Power of Suppliers
4.1.6.4. The threat of Substitute Grades
4.1.6.5. The intensity of Competitive Rivalry
4.1.7. Value Chain Analysis
4.1.8. Technological Roadmap
4.1.9. Regulatory landscape
4.1.10. Impact of the Covid-19 Pandemic on the Oral Solid Dosage Pharmaceutical Formulation Market
5. Supply Side and Demand Side Indicators
6. Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecast, 2022-2029
6.1. Oral Solid Dosage Pharmaceutical Formulation Market Size & Y-o-Y Growth Analysis.
7. Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
7.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
7.1.1. Capsules
7.1.2. Tablets
7.1.3. Powder
7.1.4. Others
7.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
7.2.1. Immediate Release
7.2.2. Extended Release
7.2.2.1. Sustained Release
7.2.2.2. Controlled Release
7.2.3. Others
7.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
7.3.1. Hospital pharmacies
7.3.2. Retail pharmacies
7.3.3. Drug Stores
7.3.4. Online Pharmacy
8. Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, By Region
8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029
8.1.1. North America
8.1.2. Europe
8.1.3. Asia-Pacific
8.1.4. Middle East & Africa
8.1.5. South America
9. North America Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
9.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
9.1.1. Capsules
9.1.2. Tablets
9.1.3. Powder
9.1.4. Others
9.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
9.2.1. Immediate Release
9.2.2. Extended Release
9.2.2.1. Sustained Release
9.2.2.2. Controlled Release
9.2.3. Others
9.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
9.3.1. Hospital pharmacies
9.3.2. Retail pharmacies
9.3.3. Drug Stores
9.3.4. Online Pharmacy
10. North America Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, By Country
10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
10.1.1. US
10.1.2. Canada
10.1.3. Mexico
11. U.S. Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
11.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
11.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
11.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
12. Canada Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
12.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
12.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
12.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
13. Mexico Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
13.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
13.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
13.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
14. Europe Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
14.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
14.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
14.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
15. Europe Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, By Country
15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
15.1.1. U.K
15.1.2. France
15.1.3. Germany
15.1.4. Italy
15.1.5. Spain
15.1.6. Sweden
15.1.7. CIS Countries
15.1.8. Rest of Europe
16. U.K Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
16.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
16.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
16.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
17. France Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
17.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
17.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
17.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
18. Germany Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
18.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
18.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
18.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
19. Italy Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
19.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
19.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
19.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
20. Spain Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
20.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
20.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
20.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
21. Sweden Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
21.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
21.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
21.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
22. CIS Countries Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
22.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
22.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
22.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
23. Rest of Europe Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
23.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
23.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
23.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
24. Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
24.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
24.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
24.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
25. Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, by Country
25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
25.1.1. China
25.1.2. India
25.1.3. Japan
25.1.4. South Korea
25.1.5. Australia
25.1.6. ASEAN
25.1.7. Rest of Asia Pacific
26. China Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
26.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
26.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
26.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
27. India Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
27.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
27.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
27.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
28. Japan Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
28.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
28.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
28.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
29. South Korea Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
29.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
29.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
29.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
30. Australia Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
30.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
30.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
30.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
31. ASEAN Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
31.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
31.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
31.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
32. Rest of Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
32.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
32.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
32.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
33. Middle East Africa Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
33.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
33.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
33.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
34. Middle East Africa Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, by Country
34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029
34.1.1. South Africa
34.1.2. GCC Countries
34.1.3. Egypt
34.1.4. Nigeria
34.1.5. Rest of ME&A
35. South Africa Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
35.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
35.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
35.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
36. GCC Countries Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
36.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
36.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
36.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
37. Egypt Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
37.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
37.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
37.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
38. Nigeria Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
38.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
38.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
38.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
39. Rest of ME&A Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
39.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
39.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
39.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
40. South America Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
40.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
40.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
40.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
41. South America Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, by Country
41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029
41.1.1. Brazil
41.1.2. Argentina
41.1.3. Rest of South America
42. Brazil Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
42.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
42.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
42.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
43. Argentina Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
43.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
43.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
43.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
44. Rest of South America Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecasts, 2022-2029
44.1. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029
44.2. Market Size (Value) Estimates & Forecast By Drug Release Mechanism, 2022-2029
44.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029
45. Competitive Landscape
45.1. Geographic Footprint of Major Players in the Oral Solid Dosage Pharmaceutical Formulation Market
45.2. Competition Matrix
45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Grades, and R&D Investment
45.2.2. New Grade Launches and Grade Enhancements
45.2.3. Market Consolidation
45.2.3.1. M&A by Regions, Investment, and Verticals
45.2.3.2. M&A, Forward Integration and Backward
Integration
45.2.3.3. Partnership, Joint Ventures, and Strategic Alliances/ Sales Agreements
45.3. Company Profile: Key Players
45.3.1. Merck & Co., Inc., d.b.a
45.3.1.1. Financial Overview
45.3.1.2. Geographic Footprint
45.3.1.3. Grade Portfolio
45.3.1.4. Business Strategy
45.3.1.5. Recent Developments
45.3.2. Takeda Pharmaceutical Company Limited
45.3.3. Corealis Pharma Inc.
45.3.4. Astellas Pharma Inc.
45.3.5. CordenPharma International
45.3.6. Bayer AG
45.3.7. AbbVie Inc.
45.3.8. Thermo Fisher Scientific Inc. (Patheon N.V.)
45.3.9. Lonza
45.3.10. Catalent Inc.
45.3.11. Alcami Corporation
45.3.12. Halo Pharmaceutical Inc.
45.3.13. CordenPharma International
45.3.14. Arnet Pharmaceuticals
45.3.15. Jubilant Life Sciences
45.3.16. Pfizer Inc.
45.3.17. Piramal EnterprisesLtd
45.3.18. Metrics Contract Services
45.3.19. GENVION Corporation
45.3.20. GlaxoSmithKline plc.
45.3.21. CMIC HOLDINGS Co., LTD.
45.3.22. Tower Laboratories Ltd.
45.3.23. PNP Pharmaceuticals Inc.
45.3.24. Confab Laboratories Inc.
45.3.25. Wockhardt Ltd.
45.3.26. Pharma Tech Industries
47.Primary Key Insights
  • INQUIRE BEFORE BUYING